Fort Lauderdale, FL · Health Care · Form D filed Sep 1, 2026

Kaida BioPharma Inc. raised $1.6M

Kaida BioPharma Inc. is a biotechnology company based in Fort Lauderdale, Florida. In an amended Form D filed with the SEC on September 1, 2026, it reported raising $1,600,507 from 44 investors as part of an offering of up to $4,100,507. The first sale in the offering took place on October 24, 2023.

View the SEC filing Find on LinkedIn People at this company

3rd Form D since 2023. Earlier new notices: Jan 21, 2026 · Jun 14, 2023. All filings on EDGAR
Still raising. $2.5M of the $4.1M offering was still unsold at filing.

$1.6M raised since 2020

2 Form D offerings, as reported to the SEC, the first in Jun 14, 2023. Amendments update a round; they aren't counted twice.

Filed	Sold	Offering size	Investors
Jan 21, 2026	$1.6M	$4.1M	44
Jun 14, 2023	$4K	$4K	47

Lead score

26 out of 100

early raise still raising budget to spend

Outreach kit How it works 1:21

A first message that shows you did your homework, written from this filing. Fill in the brackets and send.

Email · subject: Congrats on the new round

Hi [first name],

Congrats on the new round. I saw the raise in your SEC filing.

Teams at this stage usually start looking at [what you do] right after a round...

[Your name]

LinkedIn note

Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?

Call opener

Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...

Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing

Track this company How it works 0:56

Saved to your dashboard pipeline, with a badge in Explore.

Loading your outreach kit…

The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.

Start your free trial Already on Pro? Sign in

Filing details

Amount raised: $1,600,507
Offering size: $4,100,507
Investors so far: 44
First sale: October 24, 2023
Securities offered: Equity
Exemption claimed: Rule 506(b)
Industry: Biotechnology
Headquarters: Fort Lauderdale, Florida
Incorporated: Delaware, 2022
Entity type: Corporation

Filings

Filed	Form	Raised	Offering size	Investors	Source
Sep 1, 2026	D/A (amendment)	$1,600,507	$4,100,507	44	SEC filing

Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.

Updated September 1, 2026 · Raises in the week of Aug 31, 2026 · Health Care funding in Florida · September 2026 funding report

Similar raises

All health care raises →

Technology $2.6M

Equidefi Ltd.

Fort Lauderdale, FL · filed Oct 1

EquiDeFi® is a revolutionary new choice for launching and managing private offerings. Designed with SEC compliance foremost in mind.

3rd Form D since 2022Still raising

Technology $125K

Debit My Data, Inc.

Fort Lauderdale, FL · filed Sep 3

2nd Form D since 2024Still raising

Health Care $150K

Lurex Bio, Inc.

Fort Lauderdale, FL · filed Aug 31

LurexBio is developing a non genetic, non viral recognition engineering platform to address an important component of tumor immune evasion in immune cold cancers.

2nd Form D since 2026

Technology $250K

USA Made in America Inc.

Fort Lauderdale, FL · filed Aug 20

First Form DStill raising

Health Care $613K

Immorta Bio, Inc.

Miami Beach, FL · filed Oct 16

2nd Form D since 2026Still raising

Health Care $49.8M

Curadel Surgical Innovations, Inc.

Bonita Springs, FL · filed Oct 13

4th Form D since 2023Still raising

Health Care $3M

BioStem Technologies, Inc.

Pompano Beach, FL · filed Oct 9

BioStem Technologies® produces innovative perinatal tissue-based allografts, including VENDAJE®, VENDAJE AC® and VENDAJE® optic.

7th Form D since 2016

Health Care $250K

Lev 18, Inc.

Surfside, FL · filed Oct 9

First Form D